---
title: Spark Therapeutics eBook
---

- <https://twitter.com/medcitynews>
- <https://www.facebook.com/medcitynews>
- <http://medcitynews.com/feed/>
- <http://cloud.feedly.com/#subscription%2Ffeed%2Fhttp%3A%2F%2Fmedcitynews.com%2Ffeed%2F>
- <http://medcitynews.com/subscribe/>

- [Send Tips](mailto:tips@medcitynews.com)
- [Advertising](http://medcitynews.com/ads/)
- [About](http://medcitynews.com/about-us/)

[![MedCity News](https://info.medcitynews.com/hubfs/Medcitynews-June2016-Images/logo2.png)](http://medcitynews.com/)

- [NEWS](https://medcitynews.com/news/)
- [CONTRIBUTORS](https://medcitynews.com/contributors/)
- [EVENTS](https://events.medcitynews.com/)
- [PODCASTS](https://medcitynews.com/medcity-podcasts/)
- [NEWSLETTERS](https://medcitynews.com/subscribe/)

- [About Us](http://medcitynews.com/about-us/)
- [Advertising](http://medcitynews.com/ads/)
- [Contact us](http://medcitynews.com/contact-us/)

Search

[![ MedCity News](https://info.medcitynews.com/hubfs/Medcitynews-June2016-Images/mobile-logo.png)](http://medcitynews.com/)

- [Home](http://medcitynews.com/)
- [Biotech](http://medcitynews.com/category/channel/biotech/)
- [Diagnostics](http://medcitynews.com/category/channel/diagnostics/)
- [Health IT](http://medcitynews.com/category/channel/health-it-channel/)
- [Medical Devices](http://medcitynews.com/category/channel/medical-devices-channel/)
- [Payers](http://medcitynews.com/category/channel/payers/)
- [Pharma](http://medcitynews.com/category/channel/pharma-channel/)
- [Policy & Regulation](http://medcitynews.com/category/channel/politics-channel/)
- [Providers](http://medcitynews.com/category/channel/hospitals-channel/)
- [Population Health](http://medcitynews.com/tag/population-health/)
- [Events](http://events.medcitynews.com/)

- [About Us](http://medcitynews.com/about-us/)
- [Advertising](http://medcitynews.com/ads/)
- [Contact us](http://medcitynews.com/contact-us/)

- [Send Tips](mailto:tips@medcitynews.com)
- [Advertising](http://medcitynews.com/ads/)
- [About](http://medcitynews.com/about-us/)

- <https://twitter.com/medcitynews>
- <https://www.facebook.com/medcitynews>
- <http://medcitynews.com/feed/>
- <http://cloud.feedly.com/#subscription%2Ffeed%2Fhttp%3A%2F%2Fmedcitynews.com%2Ffeed%2F>
- <http://medcitynews.com/subscribe/>

## **Download our eBook, Spark Therapeutics: The journey of a gene therapy company from spinout to big pharma acquisition**

![](https://info.medcitynews.com/hs-fs/hubfs/image-11.png?width=300&name=image-11.png)What does it take for a life science company with a breakthrough therapy to have a successful exit? Spark Therapeutics offers up an interesting example.

When Spark secured FDA approval for Luxturna, it was the first for a gene therapy targeting a disease caused by a single faulty gene. The one-time treatment for adults and children also filled an unmet need for a form of inherited retinal degeneration that can lead to progressive vision loss and blindness.

MedCity News reporters have tracked the progress of Spark since the Philadelphia-based business spun out of Children’s Hospital of Philadelphia Center for Cellular & Molecular Therapeutics and all the way through its acquisition by Roche this year.

© 2025 Breaking Media, Inc. All rights reserved. Registration or use of this site constitutes acceptance of our [Terms of Service](http://medcitynews.com/medcitizen-terms-of-service) and [Privacy Policy](http://medcitynews.com/privacy-policy).